Snapshot · Matt and Shane's Secret Podcast
A reportedly real statistic suggests judges are more likely to deny parole or give harsher rulings when they haven't eaten yet, and more lenient right after lunch.
Where this was said
At 47:27 · chapter starts 41:10
Nate's shooting hobby and the price of 5.56 ammo leads to a wide-ranging riff on whether being a cop would actually be chill. Matt's verdict: you'd need serious connections to avoid shift work, because the rotating schedule alone would destroy your sleep. Shane suggests a 10 to 4 slot would be ideal — avoiding both morning hangovers and afternoon misery. The funniest pivot: Matt imagines the specific horror of eating a meatball sandwich and three Starbucks refreshers, only to get an urgent radio call requiring a full sprint after a pipe thief. A boa constrictor, he points out, knows to lie still for four days after eating prey. From there, Nate drops the hungry judge statistic — parole hearings close to lunchtime result in harsher sentences, while post-lunch decisions trend more lenient. [1] — Nate Marshall "Hungry judges give harsher sentences: A reportedly real statistic suggests judges are more likely to deny parole or give harsher rulings wh…" 47:27 The guys run with it, imagining defendants slipping Snickers bars to their honor. The conversation briefly gets crude about female judges and periods, which they themselves clock as going a bit far.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.